With the active participation of JSC "NC" Kazakhstan Engineering "and JSC" NC "KAZAKH INEVST" the possibility of localizing the production of artificial lung ventilation devices (IVL) is being considered.
Thus, within the framework of interstate negotiations with the participation of the Embassy of the Republic of Kazakhstan in the Republic of Turkey, the possibility of localizing the production of Biovent ventilators from Biosys on the basis of the Kazakh-Turkish joint venture Kazakhstan Aselsan Engineering LLP, whose serial production was launched in April 2020 in Turkey, is being considered.
IVL Biovent was developed in a short time by a consortium of Turkish companies ASELSAN, Bilkent, Biosys, Arçelik.
At present, IVL Biovent has been provided for testing at the City Infection Center of Nur-Sultan.
Press service of JSC "NC" Kazakhstan Engineering "